XML 137 R112.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Nov. 21, 2019
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating activities                        
Net income   $ 220,150 $ 37,360 $ 18,590 $ (30,010) $ 53,823 $ 169,328 $ 93,903 $ 140,962 $ 246,090 $ 458,016 $ 174,645
Adjustments to reconcile net income to net cash provided by operating activities:                        
Accrual of discount on equity security                   25,846 19,204 15,431
Change in fair value of derivatives                   (906,201) 777,575 (1,678,956)
Loss on extinguishment of debt   2,001 $ 0 $ 0 0         2,001 0 18,817
Share-based compensation                   11,295 11,097 6,464
Deferred income taxes                   56,947 (12,563) (46,730)
Changes in operating assets and liabilities:                        
Other assets                   (5,607) (844) 448
Other liabilities                   (28,607) (17,318) (84,416)
Net cash provided by operating activities                   3,351,402 43,185 1,923,847
Investing activities                        
Purchases of property, plant and equipment                   (4,022) (4,283) (4,809)
Net cash used in investing activities                   (3,054,886) (2,408,331) (2,593,390)
Financing activities                        
Financing fees incurred and deferred                   0 0 (5,817)
Repayment of notes payable                   0 0 (413,252)
Repayment of loan payable                   0 0 (100,000)
Proceeds from issuance of notes payable                   0 0 499,650
Repayment of subordinated debentures                   (88,160) 0 0
Proceeds from issuance of common stock, net                   1,691 9,681 14,028
Proceeds from issuance of preferred stock, net $ 388,900                 388,893 0 0
Dividends paid                   (27,304) (25,265) (23,148)
Net cash provided by (used in) financing activities                   1,652,480 1,275,497 1,312,322
Increase (decrease) in cash and cash equivalents                   1,948,996 (1,089,649) 642,779
Cash and cash equivalents at beginning of year         344,396       1,434,045 344,396 1,434,045 791,266
Cash and cash equivalents at end of year   2,293,392       344,396       2,293,392 344,396 1,434,045
Cash paid during the year for interest:                        
Interest paid                   42,879 39,575 55,445
Parent Company                        
Operating activities                        
Net income                   246,090 458,016 174,645
Adjustments to reconcile net income to net cash provided by operating activities:                        
Provision for depreciation and amortization                   1,136 916 1,610
Accrual of discount on equity security                   (8) (8) (7)
Equity in undistributed income of subsidiaries                   (216,724) (411,094) (165,572)
Change in fair value of derivatives                   945 (1,325) (657)
Loss on extinguishment of debt                   2,001 0 18,817
Accrual of discount on debenture issued to subsidiary trust                   270 254 236
Share-based compensation                   2,923 1,626 951
Deferred income taxes                   2,087 40 1,583
Changes in operating assets and liabilities:                        
Receivable from subsidiaries                   (40) (1,004) 16
Federal income tax recoverable/payable                   382 9,951 (4,673)
Other assets                   (1,229) (229) 158
Other liabilities                   (1,846) 4,860 (12,427)
Net cash provided by operating activities                   35,987 62,003 14,680
Investing activities                        
Repayment of equity securities                   2,660 0 0
Contribution to subsidiary                   (50,000) 0 0
Purchases of property, plant and equipment                   (117) (29) (45)
Net cash used in investing activities                   (47,457) (29) (45)
Financing activities                        
Financing fees incurred and deferred                   0 0 (5,817)
Repayment of notes payable                   0 0 (413,252)
Repayment of loan payable                   0 0 (100,000)
Proceeds from issuance of notes payable                   0 0 499,650
Repayment of subordinated debentures                   (88,160) 0 0
Proceeds from issuance of common stock, net                   1,691 9,681 14,028
Proceeds from issuance of preferred stock, net                   388,893 0 0
Dividends paid                   (27,304) (25,265) (23,152)
Net cash provided by (used in) financing activities                   275,120 (15,584) (28,543)
Increase (decrease) in cash and cash equivalents                   263,650 46,390 (13,908)
Cash and cash equivalents at beginning of year         $ 68,876       $ 22,486 68,876 22,486 36,394
Cash and cash equivalents at end of year   $ 332,526       $ 68,876       332,526 68,876 22,486
Parent Company | Notes and Loan Payable                        
Cash paid during the year for interest:                        
Interest paid                   25,000 25,000 40,537
Parent Company | Subordinated Debentures                        
Cash paid during the year for interest:                        
Interest paid                   $ 16,891 $ 13,593 $ 14,573